Trends in Skeletal Muscle Relaxant Prescribing Examined
Office visits with prescribed SMR nearly doubled; tripling in visits for continued SMR drug therapy.
Nonnarcotic Analgesics
CDC: 10.7% of US Adults Used Rx Pain Meds in 2015 to 2018
No change found in use of prescription opioids from 2009-2010 to 2017-2018, but increase seen in nonopioid meds
Implantable Neurostimulation Device Cleared for Chronic Low Back Pain
The FDA has approved ReActiv8® (Mainstay Medical), an implantable neurostimulation system, for the treatment of intractable chronic low back
Tanezumab Improves Pain, Function in Chronic Low Back Pain
Low back pain intensity at week 16 was improved with tanezumab 10 mg versus placebo.
Topical Amitriptyline Gets Orphan Drug Designation for Erythromelalgia
The FDA has granted Orphan Drug designation to ATX01 (proprietary topical amitriptyline; AlgoTherapeutix) for the treatment of erythromelalgia.
Evidence Supporting Use of Compounded Topical Pain Creams Limited
“In context of the recent rise in supply and demand of compounded preparations, lack of evidence regarding systemic absorption of ingredients used in compounded topical pain creams gives rise to a substantial public health concern,” the authors concluded.
Pain Medication Recalled Due to Presence of Particulate Matter in Vials
Ketorolac tromethamine injection, a nonsteroidal anti-inflammatory drug, is indicated for the short-term (≤5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting.
Nonopioid Drug Therapies Evaluated for Chronic Pain
Various electronic databases were accessed to obtain randomized controlled trials (RCTs) evaluating nonopioid agents in chronic pain patients. The review focused on 7 chronic pain conditions, including neuropathic pain, fibromyalgia, osteoarthritis, inflammatory arthritis, low back pain, chronic headache, and sickle cell disease.
New Drug Product: Anjeso
This slideshow shows drug information for Anjeso. Click here for the complete Anjeso monograph.
Acute Neurologic Deficit Linked to Salicylate Toxicity
Due to her neurologic presentation, age, and past medical history, stroke was initially considered.
